Rituximab is an effective treatment in patients with established rheumatoid arthritis (RA). The objective of the IMAGE study was to determine the efficacy of rituximab in the prevention of joint damage and its safety in combination with methotrexate (MTX) in patients initiating treatment with MTX.

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial / Tak, Pp; Rigby, Wf; Rubbert Roth, A; Peterfy, Cg; van Vollenhoven, Rf; Stohl, W; Hessey, E; Chen, A; Tyrrell, H; Shaw, Tm; Aelion J, IMAGE I. n. v. e. s. t. i. g. a. t. o. r. s.; Afif, N; Ahmadi, F; Aires, F; Alanis, E; Alonso, Cs; Alten, Rh; Alvaro Gracia, Jm; Ashrafzadeh, A; Ballina, J; Bambara, Lm; Bao, C; Bell, M; Berney, S; Bessette, L; Birbara, C; Boling, E; Bourgeois, P; Braun, J; Briones, H; Brzezicki, J; Burgos Vargos, R; Burmester, G; Burnett, M; Busch, H; Cabello, E; Calvo, A; Cantagrel, A; Cantini, F; Zea, Ac; Carreño Perez, L; Chavez, J; Shim, Sc; Chindalore, V; Chiriac, R; Codding, C; Danda, D; Del Guidice, J; De Vita, S; Digiovanni, R; Dikranian, A; Eider, W; Fantini, F; Ferraccioli, G; Fietchner, J; Filipowicz Sosnowska, A; Finnanger, B; Fiocco, G; Fleck, M; Fleischmann, R; Fraser, A; Gaudin, P; Gauler, G; Gaylis, N; Gerlag, Dm; Godde, J; Gomez Reino, Jj; Gornisiewicz, M; Gough, W; Greenwald, M; Guerra, G; Hackshaw, K; Haentzschel, Hm; Hammond, T; Hazleman, Bl; Heilig, B; Herenius, Mm; Hilliquin, P; Holt, D; Huang, F; Huff, J; Huizinga, T; Isaacs, J; Jaffer, A; Amante, Ej; Jeka, S; Jimenez, R; Jones, G; Jones, R; Kaine, J; Kashif, A; Kaufmann, C; Kay, J; Khraishi, M; Kivitz, A; Klinkhoff, A; Kraag, G; Krystufkova, O; Kucharz, E; Lawson, J; Leirisalo Repo, M; Levin, R; Liang, G; Liang, P; Limonta, M; Lowenstein, M; Rodriguez Lozano, C; Lue, C; Mahowald, M; Maradiaga, M; Maricic, M; Mariette, X; Martin, L; Massarotti, E; Matucci Cerinic, M; Montecucco, Cm; Mazurov, V; Mcnally, J; Mehta, D; Meyer, O; Misra, R; Moreland, Lw; Mueller Ladner, U; Myerson, G; Nasonov, E; Navarra, S; Navarro, F; Neal, N; Olech, E; Olsen, N; Pablos, Jl; Pacheco, C; Pal, S; Palomo, Er; Pandith, V; Penserga, Eg; Prupas, H; Radominski, S; Ramos Remus, C; Reid, D; Riordan, K; Rosenberg, D; Ruiz, A; Saadeh, C; Salvarani, Carlo; Samuels, A; Sanmarti, R; Sarzi Puttini, P; Saxe, P; Schechtman, J; Scoville, C; Sedlackova, M; Sedrish, M; Sejer Hansen, M; Sibilia, J; Siebert, S; Specker, C; Stern, S; Szechinski, J; Tahir, H; Taylor, A; Thompson, Pw; Tony, Hp; Tornero, J; Trapp, R; Tremblay, Jl; Valesini, G; Van Den Bosch, F; Wanchu, A; Wassenberg, S; Ximenes, Ac; Kim, Hy; Zanetakis, E; Zazueta, B; Zerbini, C.. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 70:1(2011), pp. 39-46. [10.1136/ard.2010.137703]

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.

SALVARANI, CARLO;
2011

Abstract

Rituximab is an effective treatment in patients with established rheumatoid arthritis (RA). The objective of the IMAGE study was to determine the efficacy of rituximab in the prevention of joint damage and its safety in combination with methotrexate (MTX) in patients initiating treatment with MTX.
2011
70
1
39
46
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial / Tak, Pp; Rigby, Wf; Rubbert Roth, A; Peterfy, Cg; van Vollenhoven, Rf; Stohl, W; Hessey, E; Chen, A; Tyrrell, H; Shaw, Tm; Aelion J, IMAGE I. n. v. e. s. t. i. g. a. t. o. r. s.; Afif, N; Ahmadi, F; Aires, F; Alanis, E; Alonso, Cs; Alten, Rh; Alvaro Gracia, Jm; Ashrafzadeh, A; Ballina, J; Bambara, Lm; Bao, C; Bell, M; Berney, S; Bessette, L; Birbara, C; Boling, E; Bourgeois, P; Braun, J; Briones, H; Brzezicki, J; Burgos Vargos, R; Burmester, G; Burnett, M; Busch, H; Cabello, E; Calvo, A; Cantagrel, A; Cantini, F; Zea, Ac; Carreño Perez, L; Chavez, J; Shim, Sc; Chindalore, V; Chiriac, R; Codding, C; Danda, D; Del Guidice, J; De Vita, S; Digiovanni, R; Dikranian, A; Eider, W; Fantini, F; Ferraccioli, G; Fietchner, J; Filipowicz Sosnowska, A; Finnanger, B; Fiocco, G; Fleck, M; Fleischmann, R; Fraser, A; Gaudin, P; Gauler, G; Gaylis, N; Gerlag, Dm; Godde, J; Gomez Reino, Jj; Gornisiewicz, M; Gough, W; Greenwald, M; Guerra, G; Hackshaw, K; Haentzschel, Hm; Hammond, T; Hazleman, Bl; Heilig, B; Herenius, Mm; Hilliquin, P; Holt, D; Huang, F; Huff, J; Huizinga, T; Isaacs, J; Jaffer, A; Amante, Ej; Jeka, S; Jimenez, R; Jones, G; Jones, R; Kaine, J; Kashif, A; Kaufmann, C; Kay, J; Khraishi, M; Kivitz, A; Klinkhoff, A; Kraag, G; Krystufkova, O; Kucharz, E; Lawson, J; Leirisalo Repo, M; Levin, R; Liang, G; Liang, P; Limonta, M; Lowenstein, M; Rodriguez Lozano, C; Lue, C; Mahowald, M; Maradiaga, M; Maricic, M; Mariette, X; Martin, L; Massarotti, E; Matucci Cerinic, M; Montecucco, Cm; Mazurov, V; Mcnally, J; Mehta, D; Meyer, O; Misra, R; Moreland, Lw; Mueller Ladner, U; Myerson, G; Nasonov, E; Navarra, S; Navarro, F; Neal, N; Olech, E; Olsen, N; Pablos, Jl; Pacheco, C; Pal, S; Palomo, Er; Pandith, V; Penserga, Eg; Prupas, H; Radominski, S; Ramos Remus, C; Reid, D; Riordan, K; Rosenberg, D; Ruiz, A; Saadeh, C; Salvarani, Carlo; Samuels, A; Sanmarti, R; Sarzi Puttini, P; Saxe, P; Schechtman, J; Scoville, C; Sedlackova, M; Sedrish, M; Sejer Hansen, M; Sibilia, J; Siebert, S; Specker, C; Stern, S; Szechinski, J; Tahir, H; Taylor, A; Thompson, Pw; Tony, Hp; Tornero, J; Trapp, R; Tremblay, Jl; Valesini, G; Van Den Bosch, F; Wanchu, A; Wassenberg, S; Ximenes, Ac; Kim, Hy; Zanetakis, E; Zazueta, B; Zerbini, C.. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 70:1(2011), pp. 39-46. [10.1136/ard.2010.137703]
Tak, Pp; Rigby, Wf; Rubbert Roth, A; Peterfy, Cg; van Vollenhoven, Rf; Stohl, W; Hessey, E; Chen, A; Tyrrell, H; Shaw, Tm; Aelion J, IMAGE I. n. v. e....espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1078950
Citazioni
  • ???jsp.display-item.citation.pmc??? 70
  • Scopus 251
  • ???jsp.display-item.citation.isi??? 229
social impact